Inclusion body myositis: evolving concepts.
Perez-Rosendahl M, Mozaffar T.
Curr Opin Neurol. 2022 Oct 1;35(5):604-610. doi: 10.1097/WCO.0000000000001095.
Inclusion body myositis: an update.
Anderson NC, Lloyd TE.
Curr Opin Rheumatol. 2025 Jan 1;37(1):80-85. doi: 10.1097/BOR.0000000000001060. Epub 2024 Oct 21.
Inclusion Body Myositis.
Goyal NA.
Continuum (Minneap Minn). 2022 Dec 1;28(6):1663-1677. doi: 10.1212/CON.0000000000001204.
Inclusion body myositis: clinical features and pathogenesis.
Greenberg SA.
Nat Rev Rheumatol. 2019 May;15(5):257-272. doi: 10.1038/s41584-019-0186-x.
Current biomarkers in inclusion body myositis.
Daniel E, Smith IC, Sampaio ML, Melkus G, Hamilton LE, Bourque PR, Warman-Chardon J.
J Neuromuscul Dis. 2024 Nov;11(6):1165-1179. doi: 10.1177/22143602241286712. Epub 2024 Oct 29.
Inclusion Body Myositis.
Naddaf E.
Continuum (Minneap Minn). 2025 Oct;31(5):1372-1384. doi: 10.1212/cont.0000000000001616. Epub 2025 Oct 2.
Inclusion body myositis, viral infections, and TDP-43: a narrative review.
Văcăraş V, Vulturar R, Chiş A, Damian L.
Clin Exp Med. 2024 May 2;24(1):91. doi: 10.1007/s10238-024-01353-9.
Inclusion body myositis.
Dimachkie MM, Barohn RJ.
Neurol Clin. 2014 Aug;32(3):629-46, vii. doi: 10.1016/j.ncl.2014.04.001. Epub 2014 Jun 6.
Inclusion body myositis: from genetics to clinical trials.
Nagy S, Khan A, Machado PM, Houlden H.
J Neurol. 2023 Mar;270(3):1787-1797. doi: 10.1007/s00415-022-11459-3. Epub 2022 Nov 18.
Phenotypic spectrum of inclusion body myositis.
Roy B, Dimachkie MM, Naddaf E.
Clin Exp Rheumatol. 2024 Feb;42(2):445-453. doi: 10.55563/clinexprheumatol/fhrx3q. Epub 2024 Feb 28.
